Viewing Study NCT05483868


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2025-12-27 @ 5:36 AM
Study NCT ID: NCT05483868
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2022-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Sponsor: Aura Biosciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module